PIK3CA and cervical carcinoma: PIK3CA mutations were detected in 146 of the total 990 patients with cervical cancer (146/990, 14.7%), including 132 mutations at exon 9 (132/990, 13.3%) and 14 mutations at exon 20 (20/990, 1.4%).